Skip header and navigation

13 records – page 1 of 1.

24-hour urine collection : split daytime and nightime

https://libcat.nshealth.ca/en/permalink/chpams36496
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1940
Available Online
View Pamphlet
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Urinalysis
Subjects (LCSH)
Urine--Analysis
Abstract
Step-by-step instructions are provided to collect a 24 hour split urine sample. Locations for drop offs (24 hour access) are included.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1940
Less detail

Cefazolin for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35860
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1818
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as cefazolin. This pamphlet explains some of the possible side effects of cefazolin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Cefazolin for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as cefazolin. This pamphlet explains some of the possible side effects of cefazolin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1818
Less detail

Ceftazidime for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35861
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1819
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as ceftazidime. This pamphlet explains some of the possible side effects of ceftazidime, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Ceftazidime for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as ceftazidime. This pamphlet explains some of the possible side effects of ceftazidime, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1819
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer, which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer, which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell the body to make more red blood cells. This can cause their red blood cell count to drop and anemia to develop. How to take the medicine and possible side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Specialty
Nephrology
Hematology
Medications
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell the body to make more red blood cells. This can cause their red blood cell count to drop and anemia to develop. How to take the medicine and possible side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Gentamicin or tobramycin for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35862
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1820
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as gentamicin or tobramycin. This pamphlet explains some of the possible side effects of gentamicin and tobramycin, how to give yourself these drugs, and how to store these drugs. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Gentamicin or tobramycin for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as gentamicin or tobramycin. This pamphlet explains some of the possible side effects of gentamicin and tobramycin, how to give yourself these drugs, and how to store these drugs. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1820
Less detail

Heparin to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35407
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1494
Available Online
View Pamphlet
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Heparin - therapeutic use
Anticoagulants - therapeutic use
Subjects (LCSH)
Heparin
Anticoagulants (Medicine)
Hemodialysis
Specialty
Nephrology
Medications
Abstract
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1494
Less detail

Injectable iron and chronic kidney disease

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2015.
Pamphlet Number
1495
Available Online
View Pamphlet
Iron sucrose (Venofer®) and sodium ferric gluconate complex (Ferrlecit®) are injectable forms of iron that help your body make hemoglobin, which is found in your red blood cells. When there is not enough iron, red blood cells won't have enough hemoglobin to carry oxygen throughout your body. People with chronic kidney disease often have anemia because their red blood cell count is low. This pamphlet explains how to take the medicine, side effects to watch for, as well as instructions for how to…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2015
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Iron sucrose (Venofer®) and sodium ferric gluconate complex (Ferrlecit®) are injectable forms of iron that help your body make hemoglobin, which is found in your red blood cells. When there is not enough iron, red blood cells won't have enough hemoglobin to carry oxygen throughout your body. People with chronic kidney disease often have anemia because their red blood cell count is low. This pamphlet explains how to take the medicine, side effects to watch for, as well as instructions for how to store the medication.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1469
Available Online
View Pamphlet
Iron is needed by your red blood cells to help carry oxygen through your body. People with chronic kidney disease (CKD) often have anemia (not enough red blood cells or hemoglobin in the blood). Oral irons, such as ferrous sulfate, ferrous gluconate, ferrous fumarate, Proferrin® and FeraMAX® 150, will give you enough iron to make sure your body gets enough oxygen. How to take these medicines and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Specialty
Nephrology
Medications
Abstract
Iron is needed by your red blood cells to help carry oxygen through your body. People with chronic kidney disease (CKD) often have anemia (not enough red blood cells or hemoglobin in the blood). Oral irons, such as ferrous sulfate, ferrous gluconate, ferrous fumarate, Proferrin® and FeraMAX® 150, will give you enough iron to make sure your body gets enough oxygen. How to take these medicines and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Pneumovax 23 (pneumococcal polyvalent) vaccine and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1890
Available Online
View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Pneumovax® 23 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible si…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Pneumococcal Vaccines
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Pneumococcal vaccine
Streptococcus pneumoniae
Kidneys--Diseases
Abstract
Pneumovax® 23 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Pneumovax® 23 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible side effects, the 2 types of vaccines, who should not get vaccinated, and when to get each vaccine are reviewed.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1890
Less detail

Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1889
Available Online
View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Prevnar® 13 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible side e…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Heptavalent Pneumococcal Conjugate Vaccine
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Streptococcus pneumoniae
Kidneys--Diseases
Abstract
Prevnar® 13 is a vaccine that protects against infections caused by the Streptococcus pneumoniae bacteria. Streptococcus pneumoniae is a type of bacteria that spreads from person to person by droplets when coughing or sneezing.This bacteria can cause many types of infections such as: pneumonia, meningitis, bacteremia, sinusitis, and otitis media. Prevnar® 13 is recommended for adults with a weakened immune system as a result of kidney disease. Why you may need to get vaccinated, possible side effects, the 2 types of vaccines, who should not get vaccinated, and when to get each vaccine are reviewed.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1889
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis patients

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1445
Available Online
View Pamphlet
People with kidney disease have a greater chance of having high potassium levels. Kayexalate® is a drug that treats high potassium levels that can lead to irregular heart beat or cause problems with muscles and nerves. This pamphlet explains how to take Kayexlate®, side effects and how to store this medicine.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
People with kidney disease have a greater chance of having high potassium levels. Kayexalate® is a drug that treats high potassium levels that can lead to irregular heart beat or cause problems with muscles and nerves. This pamphlet explains how to take Kayexlate®, side effects and how to store this medicine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail

Vancomycin for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35863
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1821
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as vancomycin. This pamphlet explains some of the possible side effects of vancomycin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Vancomycin for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as vancomycin. This pamphlet explains some of the possible side effects of vancomycin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1821
Less detail

13 records – page 1 of 1.